A randomized, open label, multi-center, comparative trial, to assess the efficacy and safety of Pritelivir versus Foscarnet for the treatment of Acyclovir-resistant mucocutaneous HSV infections in immunocompromised adults

By |2019-04-24T18:00:35+00:00April 24th, 2019|